A researcher isolates natural killer (NK) cells from umbilical cord blood in a laboratory in Beijing Health-Biotech Group in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
With comprehensive precaution measures, pharmaceutical companies in Beijing have resumed production to ensure the supply of medicine.
BEIJING, Feb. 15 (Xinhua) -- Medical help is a key part of fighting COVID-19. A number of pharmaceutical companies in Beijing have resumed production to ensure the supply of medicine during the fight against the novel coronavirus epidemic.
Governments and departments at all levels have managed to do a solid job in epidemic prevention and control, while smoothly advancing work and production resumption of enterprises, rapidly increasing key medical supply, and ensuring generally ample supply of daily necessities.
A worker drives a forklift to carry medicines at a warehouse of pharmaceutical company Bayer AG in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
A worker checks the production line in a workshop of Youcare Pharmaceutical Group CO., LTD in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
A worker drives a forklift to carry medicines at a warehouse of pharmaceutical company Bayer AG in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
Researchers of Youcare Pharmaceutical Group CO., LTD test samples in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
A management personnel checks the production of medicines in a workshop of Youcare Pharmaceutical Group CO., LTD in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei)
Workers of pharmaceutical company Bayer AG dine in staff canteen in Beijing, capital of China, Feb. 14, 2020. (Xinhua/Zhang Yuwei) ■
